USANA Non Currrent Assets Other vs Other Stockholder Equity Analysis
| USNA Stock | USD 38.50 0.34 0.89% |
USANA Health financial indicator trend analysis is much more than just breaking down USANA Health Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether USANA Health Sciences is a good investment. Please check the relationship between USANA Health Non Currrent Assets Other and its Other Stockholder Equity accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Non Currrent Assets Other vs Other Stockholder Equity
Non Currrent Assets Other vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of USANA Health Sciences Non Currrent Assets Other account and Other Stockholder Equity. At this time, the significance of the direction appears to have almost no relationship.
The correlation between USANA Health's Non Currrent Assets Other and Other Stockholder Equity is 0.12. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of USANA Health Sciences, assuming nothing else is changed. The correlation between historical values of USANA Health's Non Currrent Assets Other and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of USANA Health Sciences are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Non Currrent Assets Other i.e., USANA Health's Non Currrent Assets Other and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.12 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Other Stockholder Equity
Most indicators from USANA Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into USANA Health Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, USANA Health's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.36, whereas Selling General Administrative is forecasted to decline to about 220.8 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 968.6M | 804.7M | 744.3M | 475.7M | Total Revenue | 1.2B | 998.6M | 921.0M | 585.9M |
USANA Health fundamental ratios Correlations
Click cells to compare fundamentals
USANA Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
USANA Health fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Common Stock Shares Outstanding | 22.8M | 21.3M | 20.3M | 19.3M | 19.3M | 27.4M | |
| Total Assets | 516.9M | 640.9M | 577.7M | 596.5M | 632.8M | 664.4M | |
| Other Current Liab | 101.4M | 105.0M | 104.0M | 88.8M | 83.5M | 57.3M | |
| Total Current Liabilities | 136.1M | 168.1M | 160.8M | 143.8M | 118.8M | 76.4M | |
| Total Stockholder Equity | 351.7M | 441.7M | 395.1M | 434.5M | 497.2M | 522.1M | |
| Property Plant And Equipment Net | 95.2M | 100.4M | 101.8M | 97.8M | 99.8M | 60.0M | |
| Net Debt | (226.5M) | (303.3M) | (232.8M) | (281.5M) | (317.2M) | (301.4M) | |
| Retained Earnings | 306.1M | 382.8M | 344.6M | 391.6M | 445.2M | 467.5M | |
| Accounts Payable | 12.5M | 18.2M | 13.5M | 11.0M | 10.1M | 8.2M | |
| Cash | 234.8M | 311.9M | 239.8M | 288.4M | 330.4M | 346.9M | |
| Non Current Assets Total | 187.7M | 215.6M | 212.6M | 212.2M | 215.0M | 110.8M | |
| Non Currrent Assets Other | 40.0M | 59.3M | 34.1M | 51.9M | 54.9M | 57.6M | |
| Cash And Short Term Investments | 234.8M | 311.9M | 239.8M | 288.4M | 330.4M | 346.9M | |
| Liabilities And Stockholders Equity | 516.9M | 640.9M | 577.7M | 596.5M | 632.8M | 664.4M | |
| Inventory | 68.9M | 90.2M | 98.3M | 67.1M | 61.5M | 40.7M | |
| Other Current Assets | 25.5M | 15.7M | 19.8M | 21.7M | 18.7M | 16.4M | |
| Other Stockholder Equity | 59.4M | 62.5M | 50.0M | 55.6M | 65.7M | 36.1M | |
| Total Liab | 165.2M | 199.2M | 182.6M | 162.1M | 135.6M | 88.4M | |
| Property Plant And Equipment Gross | 126.5M | 100.4M | 101.8M | 222.5M | 228.8M | 240.2M | |
| Total Current Assets | 329.3M | 425.3M | 365.1M | 384.4M | 417.7M | 438.6M | |
| Accumulated Other Comprehensive Income | (13.9M) | (3.6M) | 458K | (12.8M) | (13.7M) | (13.0M) | |
| Current Deferred Revenue | 13.9M | 16.0M | 19.6M | 20.9M | 13.9M | 12.0M | |
| Net Receivables | 8.8M | 7.4M | 7.2M | 7.2M | 7.2M | 7.0M | |
| Non Current Liabilities Total | 29.1M | 31.2M | 21.8M | 18.2M | 16.7M | 12.9M | |
| Short Term Debt | 8.3M | 8.6M | 7.1M | 6.9M | 8.1M | 11.9M | |
| Other Assets | 26.2M | 67.0M | 62.7M | 50.7M | 1.0 | 0.95 | |
| Property Plant Equipment | 95.2M | 100.4M | 101.8M | 111.7M | 128.4M | 68.0M | |
| Other Liab | 11.9M | 12.0M | 21.8M | 10.6M | 12.1M | 7.1M | |
| Good Will | 16.6M | 17.4M | 17.7M | 17.4M | 17.1M | 14.8M | |
| Intangible Assets | 29.8M | 30.8M | 30.4M | 32.4M | 29.9M | 28.3M | |
| Net Tangible Assets | 305.2M | 441.7M | 347.0M | 384.7M | 442.4M | 297.1M | |
| Retained Earnings Total Equity | 329.5M | 306.1M | 382.8M | 344.6M | 396.3M | 258.5M | |
| Capital Surpluse | 72.0M | 59.4M | 62.5M | 50.0M | 57.5M | 67.0M | |
| Deferred Long Term Liab | 13.4M | 10.3M | 12.0M | 7.5M | 8.6M | 10.3M | |
| Non Current Liabilities Other | 18.8M | 19.2M | 14.3M | 14.2M | 12.2M | 7.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.83 | Revenue Per Share 45.085 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0809 |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.